EPApost-acute coronary syndromeatherosclerotic cardiovascular disease (ASCVD)HypertriglyceridaemiaASCVDstatin therapylow-density lipoprotein (LDL)-lowering treatmentcombination lipid-regulating treatment
…eview summarises the concepts underpinning the use of high-dose EPA alongside intensive LDL-lowering therapy, especially in the con…